Machine Learning-Driven Analysis, Genetic & Epigenetic Insights Opioid Use

Friday, Sep 20, 2024 at 1:30 PM to 2:30 PM EDT

455 Main Street, McGovern Auditorium, Cambridge, MA, 02142, United States

Register Now

Registration

Sale ended

WI Innovation Initiative Seminar Series | Sept. 20, 2024 Partial Approval

Enter your discount code

  • Fee
  • Total amount

1. Select Seats

2. Review and Proceed

Friday, Sep 20, 2024 at 1:30 PM to 2:30 PM EDT

Whitehead Institute, 455 Main Street, Cambridge, MA, 02142, United States.

Machine Learning-Driven Analysis Reveals Distinct Genetic and Epigenetic Insights into Opioid Usage or Overdose

Integrating Foundation Models with Chromatin QTL Analysis Uncovers Distinct Genetic-Epigenetic Associations in Opioid Overdose

Presented by Fatir Qureshi, Corradin Lab, Whitehead Institute

 

Whitehead Institute
McGovern Auditorium
455 Main Street
Cambridge, MA 02142

Friday September 20, 2024
1:30 pm - 2:30  pm 

 

Social mixer to follow. Free and open to the scientific community. 

 

About the Whitehead Innovation Initiative

The Whitehead Innovation Initiative (WII) is a bold program advancing cutting-edge bio-AI leadership, which sponsors community-building and educational programs, funding opportunities, and computational resources at Whitehead Institute. The goal of the initiative is to spark innovation at the intersection of biomedical research and AI, foster partnerships between biomedical and computational researchers, facilitate collaboration, and support individual projects through expanded, state of the art computational infrastructure, educational resources, funding opportunities and social events.

 

Cancellation policy

If you need to cancel, please do so by Septmeber 19. Thank you.

Whitehead Institute

www.wi.mit.edu

Whitehead Institute is a world-renowned non-profit research institution dedicated to improving human health through basic biomedical research.

Contact the Organizer

Fatir Qureshi
Research Scientist
Corradin Lab, MIT

Fatir Qureshi is a research scientist in the Corradin Lab at the Whitehead Institute. His current research focus lies at the intersection of bioinformatics, epigenetics and data science. He completed his PhD in biomedical engineering at the Rensselaer Polytechnic Institute in 2022. The focus of his dissertation was leveraging machine learning techniques to better understand the biochemical underpinnings of autism spectrum disorder.

https://www.linkedin.com/in/fatir-qureshi-0a289b60/

About Fatir Qureshi

Research Scientist
Corradin Lab, MIT